124 related articles for article (PubMed ID: 37977518)
1. The critical role of phlebolymphedema in cellulitis associated with lymphedema: Its incidence and economic impact in a large real-world population.
Tedesco A; O'Donnell T; Weycker D; Salehi P
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101704. PubMed ID: 37977518
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer-related lymphedema correlated with incidence of cellulitis and mortality.
Cheng MH; Ho OA; Tsai TJ; Lin YL; Kuo CF
J Surg Oncol; 2022 Dec; 126(7):1162-1168. PubMed ID: 35960614
[TBL] [Abstract][Full Text] [Related]
3. Correlation of disease comorbidity with prescribed treatment among insured U.S. lymphedema patients.
O'Donnell TF; Izhakoff J; Gaebler JA; Niecko T; Iafrati MD
J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):461-470. PubMed ID: 32470618
[TBL] [Abstract][Full Text] [Related]
4. Health and economic benefits of advanced pneumatic compression devices in patients with phlebolymphedema.
Lerman M; Gaebler JA; Hoy S; Izhakoff J; Gullett L; Niecko T; Karaca-Mandic P; O'Donnell T; Rockson SG
J Vasc Surg; 2019 Feb; 69(2):571-580. PubMed ID: 29914829
[TBL] [Abstract][Full Text] [Related]
5. Assessment of quality of life changes in patients with lower extremity lymphedema using an advanced pneumatic compression device at home.
Maldonado TS; Rokosh RS; Padberg F; Rotella V; Miller H; Nassiri N; Jacobowitz G; Berland T; Sadek M; Barfield ME
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):745-752. PubMed ID: 33137494
[TBL] [Abstract][Full Text] [Related]
6. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.
Shih YC; Xu Y; Cormier JN; Giordano S; Ridner SH; Buchholz TA; Perkins GH; Elting LS
J Clin Oncol; 2009 Apr; 27(12):2007-14. PubMed ID: 19289624
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for developing upper limb cellulitis after breast cancer treatment.
Engin O; Sahin E; Saribay E; Dilek B; Akalin E
Lymphology; 2022; 55(2):77-83. PubMed ID: 36170582
[TBL] [Abstract][Full Text] [Related]
8. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer-related lymphedema and its treatment: how big is the financial impact?
De Vrieze T; Gebruers N; Nevelsteen I; Tjalma WAA; Thomis S; De Groef A; Dams L; Haenen V; Devoogdt N
Support Care Cancer; 2021 Jul; 29(7):3801-3813. PubMed ID: 33236211
[TBL] [Abstract][Full Text] [Related]
10. Association Between Access to Specialists and History of Cellulitis Among Patients with Lymphedema: Secondary Analysis Using the National LIMPRINT Database.
Dai M; Nakagami G; Sato A; Koyanagi H; Kohta M; Moffatt CJ; Murray S; Franks PJ; Sanada H; Sugama J
Lymphat Res Biol; 2021 Oct; 19(5):442-446. PubMed ID: 34582714
[No Abstract] [Full Text] [Related]
11. The Prevalence and Functional Impact of Chronic Edema and Lymphedema in Japan: LIMPRINT Study.
Dai M; Nakagami G; Sugama J; Kobayashi N; Kimura E; Arai Y; Sato A; Mercier G; Moffatt C; Murray S; Sanada H
Lymphat Res Biol; 2019 Apr; 17(2):195-201. PubMed ID: 30995194
[No Abstract] [Full Text] [Related]
12. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
13. The clinical characteristics of lower extremity lymphedema in 440 patients.
Dean SM; Valenti E; Hock K; Leffler J; Compston A; Abraham WT
J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):851-859. PubMed ID: 31992537
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies.
Shah C; Vicini FA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):907-14. PubMed ID: 21945108
[TBL] [Abstract][Full Text] [Related]
15. Surgical-Site Infection is Associated With Increased Risk of Breast Cancer-Related Lymphedema: A Nationwide Cohort Study.
Jørgensen MG; Gözeri E; Petersen TG; Sørensen JA
Clin Breast Cancer; 2023 Jul; 23(5):e296-e304.e2. PubMed ID: 37095025
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
[TBL] [Abstract][Full Text] [Related]
17. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment.
Farley CR; Irwin S; Adesoye T; Sun SX; DeSnyder SM; Lucci A; Shaitelman SF; Chang EI; Ueno NT; Woodward WA; Teshome M
Ann Surg Oncol; 2022 Oct; 29(10):6370-6378. PubMed ID: 35854031
[TBL] [Abstract][Full Text] [Related]
18. Interventions for the prevention of recurrent erysipelas and cellulitis.
Dalal A; Eskin-Schwartz M; Mimouni D; Ray S; Days W; Hodak E; Leibovici L; Paul M
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009758. PubMed ID: 28631307
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema.
Montagna G; Zhang J; Sevilimedu V; Charyn J; Abbate K; Gomez EA; Mehrara B; Morrow M; Barrio AV
JAMA Oncol; 2022 Aug; 8(8):1195-1200. PubMed ID: 35679026
[TBL] [Abstract][Full Text] [Related]
20. Prospective Surveillance with Compression for Subclinical Lymphedema: Symptoms, Skin, and Quality-of-Life Outcomes.
Dietrich MS; Gaitatzis K; Koelmeyer L; Boyages J; Abramson VG; McLaughlin SA; Ngui N; Elder E; French J; Hsu J; Hughes TM; Stolldorf DP; Shah C; Ridner SH
Lymphat Res Biol; 2023 Jun; 21(3):304-313. PubMed ID: 36126315
[No Abstract] [Full Text] [Related]
[Next] [New Search]
